ENFERMEDADES RESPIRATORIAS
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas Southwestern Medical Center (1)
2019
-
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
The Lancet Respiratory Medicine, Vol. 7, Núm. 11, pp. 951-963